Glenn Schulman
Head of Investor Relations
Lakefront Biotherapeutics NV (LKFT)Head of Investor Relations
X4 Pharmaceuticals, Inc (XFOR)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Glenn Schulman
Glenn Schulman is recorded as Head of Investor Relations at Lakefront Biotherapeutics NV (LKFT) and Head of Investor Relations at X4 Pharmaceuticals, Inc (XFOR). Glenn Schulman has spoken on 6 earnings calls across 3 companies, most recently for Lakefront Biotherapeutics NV on February 24, 2026.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
-
Current
-
Aurinia Pharmaceuticals Inc. (AUPH)
Source not stated
Current
Company network
Recorded roles and call appearances connecting this person to public companies.
Head of Investor Relations
Head of Investor Relations
Leadership on record at Aurinia Pharmaceuticals Inc.
Other people whose current roles at this company are on record from its filings.
- Jeffrey Bailey CEO, Board Member
- Kevin Tang CEO, Board Member
- Peter Greenleaf CEO, Board Member
- Joseph Miller CFO
- Michael Hearne CFO
- Matthew Donley COO
- Ryan Cole COO
- Stephen Robertson General Counsel
- Craig Johnson Board Member
- Dr. Karen Smith Board Member
Leadership on record at X4 Pharmaceuticals, Inc
Other people whose current roles at this company are on record from its filings.
- Adam Raymond Craig, M.D., Ph.D. CEO, Chairman, Board Member
- Michael Gray CEO
- Paula Ragan CEO
- Adam Craig Chairman
- Adam R. Craig Chairman
- Dr. Craig Chairman, Board Member
- David H. Kirske CFO
- David Kirske CFO
- Mr. Kirske CFO
- John Volpone COO
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.